Interference with MFNs suppresses mitochondrial repositioning to the cortical cytoskeleton and tumor cell invasion mediated by PI3K inhibitor therapy indicating the interplay between the AKT/PKB and MFN pathways [126]. The gene discussed is AKT1; the disease is neoplasm.